Your browser doesn't support javascript.
loading
Targeted antitumor therapy mediated by prodrug-activating mesenchymal stromal cells.
Kucerova, Lucia; Durinikova, Erika; Toro, Lenka; Cihova, Marina; Miklikova, Svetlana; Poturnajova, Martina; Kozovska, Zuzana; Matuskova, Miroslava.
Afiliación
  • Kucerova L; Laboratory of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia. Electronic address: lucia.kucerova@savba.sk.
  • Durinikova E; Laboratory of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Toro L; Laboratory of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Cihova M; Laboratory of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Miklikova S; Laboratory of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Poturnajova M; Laboratory of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Kozovska Z; Laboratory of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
  • Matuskova M; Laboratory of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Dubravska cesta 9, 845 05 Bratislava, Slovakia.
Cancer Lett ; 408: 1-9, 2017 11 01.
Article en En | MEDLINE | ID: mdl-28838843

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Profármacos / Terapia Genética / Células Madre Mesenquimatosas / Neoplasias / Antineoplásicos Idioma: En Revista: Cancer Lett Año: 2017 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Profármacos / Terapia Genética / Células Madre Mesenquimatosas / Neoplasias / Antineoplásicos Idioma: En Revista: Cancer Lett Año: 2017 Tipo del documento: Article